Pantothenic Acid

Vitamin B5 is the nutrient your cells use to build coenzyme A, a small molecule that sits at the center of how you turn food into energy and how you make and break down fats. Because B5 is water soluble, what your body does not immediately use ends up in your urine, which makes a urine test one of the most direct windows into your current vitamin B5 status.

This test is useful if you want to know whether your intake of B5 matches what your body is using, or if you are tracking metabolic patterns that show up in research on kidney disease, type 2 diabetes, and Parkinson disease. It is a research-grade marker without official clinical thresholds, so the value comes from watching your own trend rather than crossing a fixed line.

What This Test Actually Measures

Urinary pantothenic acid is the amount of vitamin B5 that leaves your body in urine over a defined window, usually 24 hours. Most of the B5 you absorb that is not built into coenzyme A passes through your kidneys unchanged, so the urine measurement closely tracks recent intake. A Nordic scientific review concluded that urine excretion is the most reliable single marker of vitamin B5 status, though no formal cutoffs for deficiency or adequacy have been agreed on.

Two real-world studies illustrate how closely intake and urine match. In a study of free-living elderly Japanese women, 24-hour urine pantothenic acid tracked diet with a correlation coefficient of about 0.59 (a moderately strong link, where 1.0 would be a perfect match). In schoolchildren, the same correlation was 0.32 (a weaker but still real link, P<0.001). Together, this means your urine value is genuinely responsive to what you ate, but day-to-day intake variation will move the number.

Why It Matters for Kidney Disease

The most direct disease-relevant urine evidence comes from research on diabetic kidney disease (DKD), a form of kidney damage caused by long-standing high blood sugar. A urine metabolomics study in people with type 2 diabetes found that pantothenic acid and related metabolites were significantly lower in those with kidney involvement, with the whole vitamin B5 to coenzyme A pathway looking disrupted. The authors proposed urinary pantothenic acid as a candidate early signal for DKD that may show change before standard kidney labs.

Urine metabolomics of systemic lupus erythematosus with kidney involvement showed similar pathway disruption: the pantothenate and coenzyme A biosynthesis pathway was altered in people with lupus nephritis, though pantothenic acid itself was not isolated as a stand-alone diagnostic marker. The shared theme is that kidney injury appears to disturb B5 handling, which is one reason urine levels can drift even when intake is steady.

Type 2 Diabetes and Cardiovascular Risk

A 2025 observational study tested whether pantothenic acid could flag type 2 diabetes and its heart and blood vessel complications. People with diabetes had lower pantothenic acid levels than healthy controls, and those with both diabetes and cardiovascular disease had the lowest levels of all. Low pantothenic acid was associated with roughly 7 to 12 times higher odds of having diabetes or diabetes with cardiovascular disease, depending on body weight. The study used circulating pantothenic acid rather than urine specifically, so this evidence supports the broader pathway being disturbed but does not directly translate into a urine threshold.

Brain Health Signals

Outside the kidney and diabetes work, pantothenic acid has appeared in brain research. A systematic review of metabolomics studies in Parkinson disease found that across the body, pantothenic acid was reduced in 12 studies and increased in 2, with pathway-level disturbance in others. A separate brain-tissue study reported lower pantothenic acid in six brain regions in dementia with Lewy bodies. These findings come from blood, cerebrospinal fluid, or tissue rather than urine, so they describe the biology that the B5 pathway can be disrupted in neurodegeneration, not that a urine reading directly predicts brain disease.

Resolving a Counterintuitive Finding

One observational study of cognitive aging reported the opposite of what you might expect: higher circulating pantothenic acid was associated with cognitive decline in ApoE-4 non-carriers and in women. The way to make sense of both findings, low pantothenic acid in many diseases and high pantothenic acid linked to cognitive decline in this study, is to treat pantothenic acid as a marker of how the body is handling fats and energy, not as a simple good number or bad number. Pathway disruption can move levels in either direction depending on what stage of disease you are looking at and what tissue or fluid you measure. A single number out of context does not pin down disease risk.

Tracking Your Trend

Because urinary pantothenic acid rises and falls with recent food intake, a single reading is more a snapshot of the last day or two than a measure of your long-term metabolic state. A study using a multivitamin found that urine excretion patterns did not always mirror what was happening in blood, which means your urine value reflects how much B5 you are eliminating after saturation, not necessarily how much your tissues have on hand.

For a marker like this, serial testing is more useful than chasing a single number. Get a baseline. If you change your diet, start or stop a B-complex supplement, or begin a medication that affects fat metabolism, retest in 3 to 6 months. After that, at least annual testing lets you see trends. Watch for sustained drops or rises across multiple readings rather than reacting to one outlier.

When Results Can Be Misleading

• Recent meals and supplements: because urine excretion tracks recent intake, a B-complex pill or a large meal in the day before collection can push values up. If you want a representative reading, keep diet and supplements consistent in the days before testing.
• Incomplete urine collection: if this test uses a 24-hour urine sample, missing a single void or extending the window can throw off the total. Follow your kit's instructions exactly and start the clock after your first morning void.
• Kidney function: kidney filtration directly determines how much vitamin B5 makes it into urine. Conditions that reduce filtration, or normal aging changes in the kidneys, can lower urinary levels without meaning your B5 status is poor.
• Fenofibrate and related drugs: in a human study, the cholesterol-lowering drug fenofibrate dropped urinary pantothenic acid more than 5-fold over 7 to 14 days by ramping up fat burning in cells. The drug is not damaging your vitamin status, but the lab number will look very low while you are on it.

What to Do With an Out-of-Pattern Result

Because no clinical thresholds exist, a single high or low reading is rarely a reason for alarm or action on its own. The more useful question is what pattern your result fits. If urinary pantothenic acid is consistently low across two collections done a few weeks apart and you have no dietary explanation, it is worth pairing this test with a kidney workup (eGFR, cystatin C, urine albumin to creatinine ratio) and basic metabolic labs (HbA1c, fasting glucose, lipids). If you are on fenofibrate or a similar PPAR alpha agonist, expect the low result and do not over-interpret it.

If the pattern is persistently low alongside markers of kidney stress or worsening glucose control, that combination is what the research connects to disease processes, not the urinary B5 number alone. In that case, a nephrologist or endocrinologist is the right person to interpret the constellation of findings, not the single value.